KBLB Kraig Biocraft Laboratories Inc. - KBLB - Page 5

QualityStocks · #41 (**permalink**) 05-29-2009, 03:51 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Announces Issuance of Stock Dividend

Kraig Biocraft Laboratories, Inc. was pleased to announce this morning that it has successfully issued its stock dividend.

CEO Kim K. Thompson stated, “The issuance of the dividend has been in the planning for some time and has been an important part of the Company’s plan for returning value to our shareholders. Just as important, we believe that the issuance has laid the groundwork for the Company’s long term future.”

He continued, “The input we have received from our shareholders throughout this process has been and continues to be overwhelmingly positive. We are also very excited about the progress in the laboratory and are very hopeful that the scientific team can maintain their tremendous forward momentum through the summer and fall and into 2010.”

QualityStocks · #42 (**permalink**) 06-02-2009, 02:30 PM

Kraig Biocraft Laboratories, Inc.’s (KBLB.OB) Target Market

The market Kraig Biocraft Laboratories has targeted is commonly referred to as the “technical textiles” market. This market encompasses a wide range of products that are used for a large number of different types of applications. The products sold into the technical textiles market are either finished products in themselves or are used as components to produce other products.

The specific sector of the technical textiles market targeted by Kraig Biocraft is known as the high-performance fibers market and can be broken down into two main areas: Aramid fibers, the best known of these fibers being DuPont’s Kevlar which produces more than $5 billion in annual sales; and ultra-high molecular weight polyethylene fibers, such as Spectra, which is produced by Honeywell International, Inc.

The worldwide market for these fibers and other high performance technical fibers is massive. It is estimated that this market generates $90 billion per year, with the United States accounting for more than half of the market. The industry has experienced significant growth over the past 10 years and is expected to continue growing at a similarly robust rate over the coming years.

QualityStocks · #43 (**permalink**) 06-05-2009, 03:14 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Recognizes Discovery to Enhance Spider Silk Strength

Kraig Biocraft Laboratories, Inc. is a biotechnology company focused on the development of commercially significant high performance polymers and technical fibers. Based on proprietary genetic engineering technology, the company is working to develop and produce polymers and protein-based materials from silkworms and spiders. Kraig Biocraft believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications.

Kraig Biocraft recently announced that scientists have discovered a way to make spider silk three times stronger by adding small amounts of metal. Even though the natural spider-made fiber is already tougher and lighter than steel, this new technique could make it useful for manufacturing super-tough textiles and high-tech medical materials, such as artificial bonds and tendons.

The discovery, published by the journal “Science”, was made by researcher Seung-Mo Lee of the Max Planck Institute of Microstructure Physics in Halle, Germany. The breakthrough addition of zinc, aluminum or titanium to a length of spider silk made it more resistant to breaking or deforming, effectively making the strand three times stronger.

Kraig Biocraft CEO Kim Thompson stated, “This new discovery is absolutely incredible. Spider silk is already known as one of the strongest fibers found in nature and is recognized for its unparalled capacity to absorb and dissipate energy in a very controlled manner. Being five times stronger than steel of the same diameter in its natural form, this enhancement reminds us again of the extraordinary potential spider silk has. Kraig Biocraft Laboratories is committed to continuing to develop sustainable spider silk for commercial use worldwide.”

QualityStocks · #44 (**permalink**) 06-10-2009, 03:41 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Looking to Spin New “Super-Fiber”

Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.

Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.

Kraig Biocraft has acquired the exclusive US rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is working directly in conjunction with leading genetic engineers at these universities to develop transgenic silkworms.

Kraig Biocraft’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers. The company expects this intellectual property portfolio to expand over the coming years.

QualityStocks · #45 (**permalink**) 06-11-2009, 04:49 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Scientific Based Efforts have Extraordinary Potential

Kraig Biocraft Laboratories’ prospects to develop a “super fiber” that can be sold into the technical textiles industry are exciting. The company’s research and development efforts are based on solid science that has been developed by some of the world’s leading genetic researchers. Kraig Biocraft is moving ever closer to the successful production of transgenic species to produce commercial quantities of spider silk.

The physical properties of spider silk are quite remarkable and commercial production of these fibers will be viewed as a major breakthrough by the scientific community. Such a development would likely yield significant coverage in the general business and popular press sectors, offering Kraig Biocraft Laboratories significant public relations exposure, which could push the price of its shares to much higher levels.

One of the major hurdles that most biotechnology companies must overcome is the FDA approval process. Fortunately for Kraig Biocraft, their technology doesn’t have to be approved by the FDA, which makes it much easier for investors to monetize their investment since the costs are significantly reduced and the time to market is much shorter. The potential for success is also much greater as only 5 out of 5,000 compounds discovered in the pre-clinical stage ever make it through the entire FDA approval process.

Should Kraig Biocraft achieve its goal of creating transgenic silkworms capable of expressing significant amounts of spider silk proteins, the technology is estimated to be immediately worth at least several hundred million dollars. Further refinement of the technology and initial acceptance by the technical textiles market could potentially yield an overall value for this technology in excess of $1 billion. With so much incredible potential, there’s no reason the company shouldn’t be on your radar.

QualityStocks · #46 (**permalink**) 06-12-2009, 02:42 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB): Big Rewards from Small Players

Dividends are often regarded as a key indicator of a company’s financial health. They also contribute significantly to a stock investor’s long-term wealth, making them a crucial factor in evaluating a company for long-term investment. In today’s economic climate, it’s even more important to build a portfolio of quality companies with the financial strength necessary to issue dividends.

A recent research study found that in the year large-cap companies first began paying dividends, or reinstated them after a lapse, they outperformed their peers by 2.7 percentage points. However, large-cap stocks aren’t the only ones that issue dividends. Small-cap and Micro-cap companies also issue various types of dividends to reward existing investors as well as attract new investors.

Although the dividend payable dates for these companies have passed, some of the recently announced micro-cap dividends include Cadence Financial Corp.’s (NASDAQ: CADE) cash dividend of $0.05; Crosstex Energy, Inc.’s (NASDAQ: XTXI) $0.09 dividend; and Unilens Vision Inc.’s $0.09 cash dividend. Companies that have upcoming dividend payable dates include Ecology and Environment, Inc.’s $0.20 six-month dividend that will be paid on or before August 7, 2009; First Keystone Corp.’s (OTCBB: FKYS) $0.23 stock dividend to be paid on June 30, 2009; and James Financial Group, Inc.’s 5% stock dividend that is payable on July 21, 2009.

One of the companies we’re watching closely that recently approved a stock dividend is Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB). The development-stage biotechnology company is focused on tapping the $92 billion market for high performance polymers and technical fibers. Kraig Biocraft has made significant progress in their labs over the past few months and is closer than ever to finding a solution for producing commercial quantities of spider silk, a super-strength fiber that has an unparalleled capacity to absorb energy and dissipate it in a very controlled manner.

QualityStocks · #47 (**permalink**) 06-16-2009, 10:57 AM

Kraig Biocraft Laboratories, Inc. (KBLB.OB): The New Silk Road

Take a minute, close your eyes, and think back to when you were in the 7th grade. At some point your geography or history teacher was probably talking to you about Marco Polo and something called the Silk Road. The Silk Road, actually a network of roads and sea routes connecting China to the Mediterranean, and ultimately to Europe, was a conduit for trade until the 15th century. Gold and silver were carried eastward to China and in return traders going back west carried something that was, pound for pound, far more valuable than even gold. They carried what was for thousands of years one of China’s major exports, natural silk, the product of a lowly caterpillar.

The reason for silk’s hold on people is, of course, its unique properties. A smooth and luxurious fiber, it can be dyed and printed in striking bright colors. It also ranks high in strength for natural fibers. Of course the silkworm isn’t the only thing that produces silk. It has been said spiders were producing silk long before silkworms even existed. In fact, spider silk has certain properties superior even to silkworm silk, such as tensile strength and the unparalleled capacity to absorb energy and dissipate it in a very controlled manner. So, why was spider silk not produced and traded?

To produce silk in volume, you need a concentrated production environment. Imagine thousands of silk worms living and working next to each other. As it turns out, spiders don’t . . . well let’s just say they don’t play well together. In fact, they tend to eat each other, which of course is not good for production. So, although people have long wanted to produce spider silk, there was no effective way to do it. What they needed was some way of combining the unique qualities of spider silk and the production capabilities of the silkworm.

Well now, for the first time in history, genetic engineering is giving us the possibility of doing just that. Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) is developing a way of actually inserting spider silk DNA directly into silkworms, allowing the silkworms to produce the proteins for spider silk. The result, it is hoped, will be the mass production of spider silk, including its tremendous tensile strength. Stronger than steel by weight, spider silk could conceivably jump to dominance in the high performance fiber market, a market worth billions, with current leaders including:

Dupont (NYSE: DD)
Honeywell (NYSE: HON)
Cytec Industries (NYSE: CYT)
Hexcel Corp. (NYSE: HXL

If Kraig Biocraft is successful, it will represent a new way of getting silk; perhaps the biggest breakthrough in silk production in a thousand years. With the company’s leading team of scientific experts and breakthroughs taking place in the lab, the world is closer than ever to experiencing the many benefits offered by this exciting technology.

QualityStocks · #48 (**permalink**) 06-19-2009, 12:50 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Continues To Grow Strong Intellectual Property Portfolio

Kraig Biocraft Laboratories, Inc., an emerging biotech company with an already strong intellectual property portfolio relating to the genetic modification of silkworms to produce spider silk, continues to strengthen its position as it develops faster and more efficient research methodologies.

The company describes its technology as a unique protein expression system that is potentially highly scalable and cost effective in producing a variety of proteins that can be marketed to the pharmaceutical and fibers markets, although spider silk remains the principal goal of the company. Kraig Biocraft has successfully inserted into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk, but work remains to be done for the actual production of spider silk.

Spider silk has elasticity and strength properties unmatched by any man-made fiber, including DuPont’s Kevlar, the most successful synthetic technical fiber ever produced, which pales in comparison to spider silk in the ability to absorb energy prior to fiber breakage. An additional advantage of spider silk is that it is derived from natural sources and is biodegradable, unlike competitive products which are manufactured using toxic and polluting chemicals. The only thing required by genetically modified silkworms is oxygen and Mulberry leaves.

And all of these spider silk qualities come in a package that is unbelievably lightweight. A strand of spider silk stretching all the way around the globe would amount to no more than a pound or two. This strand would be five times the strength of steel of the same diameter.

With these unparalleled attributes, the market possibilities for spider silk are almost countless, with a dollar value in the billions. It is estimated that DuPont pulls in well over $5 billion annually in sales of Kevlar, and the overall high performance technical fibers market is currently around $90 billion annually.

So it’s fairly conservative to predict that, should Kraig Biocraft be able to develop a commercially viable transgenic species capable of producing spider silk proteins, the discovery would immediately be worth several hundred million dollars to one of the multinational corporations involved in the technical textiles industry.

QualityStocks · #49 (**permalink**) 06-29-2009, 01:24 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Has Significant Addition to the Research Team

Kraig Biocraft Laboratories Inc. is an emerging biotech company with a strong intellectual property portfolio relating to the genetic modification of silkworms to produce spider silk. The company believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications. With spider silk as a base, the company hopes to tap into the $92 billion market for high performance and technical fibers.

Kraig Biocraft announced several months ago that genetic engineer Dr. Bong-Hee Sohn joined the research and development team to develop new high performance polymers using spider silk gene sequences. Dr. Sohn is another major addition to the research team at the company.

Dr. Sohn received her PhD from Kyung-Hee University in South Korea. Her extensive research background includes work in research labs in Japan and South Korea. One of her areas of specialty in genetic engineering is the development of novel methods for transgenic silkworm production.

Kraig Biocraft’s CEO Kim Thompson said that “Dr. Sohn has already made a significant impact on the pace and direction of our development program. This is a very exciting time for the company and for the research laboratory.”

Mr. Thompson went on “The University of Notre Dame hired Dr. Sohn to work on specific applications of genetic engineering in silkworms for polymer development and protein expression platform technologies, which are the company’s major area of focus. The company is now fully on target for significantly accelerating the pace of its R & D.”

QualityStocks · #50 (**permalink**) 07-02-2009, 05:30 PM

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Anticipates Success

Emerging biotech company, Kraig Biocraft Laboratories, Inc. was founded by the inventor of the company’s technology, current chief executive officer, Kim Thompson. The company is a fully reporting organization and trades on the over-the-counter market under the stock symbol KBLB. As of last report, there are about 501 million common shares outstanding, with approximately 64% held by the chief executive officer.

Kraig Biocraft Laboratories’ CEO serves as the overall coordinator for the company relative to business operations and ongoing research and development. Several prominent genetic scientists have significantly developed the companies’ technologies. Additionally, the laboratory staffs of these professors are also making significant contributions to the company’s efforts.

Kraig Biocraft Laboratories, Inc. has a developed intellectual portfolio relating to the harvesting of silk from genetically modified silkworms. The company brings together preeminent researchers in a collaborative effort to produce commercially significant quantities of spider silk, one of the world’s strongest and most resilient fibers.

In order to achieve this goal, the company has aligned itself with teams from the University of Notre Dame and the University of Wyoming, two leading research universities. The project includes Dr. Malcolm Fraser of Notre Dame, a noted genetic scientist and a member of the first team of researchers to develop a transgenic silkworm, and Dr. Randy Lewis of the University of Wyoming, one of the world’s foremost authorities on spider silk. The University of Wyoming, which holds significant intellectual property rights relating to the genetic sequencing of spiders, is a meaningful equity investor in the company.

Efforts to produce the desired proteins in a transgenic silkworm have significantly accelerated over the past several months, possibly leading to a breakthrough in the laboratory by the end of this year. The perfected technology required for the project is expected to arrive a year following the breakthrough.